标签归档：vp

Capsid Protein VP72 (African swine fever virus, ASFV) (rec.) 重组Capsid Protein VP72（非洲猪瘟病毒, ASFV） 品牌：AbFrontier

发表于由

Capsid Protein VP72 (African swine fever virus, ASFV) (rec.)

重组Capsid Protein VP72（非洲猪瘟病毒, ASFV）

品牌：AbFrontier
CAS No.：
储存条件：-80°C
纯度：–
产品编号

(生产商编号)

 等级 规格 运输包装 零售价(RMB) 库存情况 参考值

YIF-LF-P0429

 – 0.1 mg –

Capsid Protein VP72 (African swine fever virus, ASFV) (rec.) 重组Capsid Protein VP72（非洲猪瘟病毒, ASFV） 品牌：AbFrontier

 – –


* 干冰运输、大包装及大批量的产品需酌情添加运输费用


* 零售价、促销产品折扣、运输费用、库存情况、产品及包装规格可能因各种原因有所变动，恕不另行通知，确切详情请联系上海金畔生物科技有限公司。

D[LEU4,LYS8]-VP

发表于由

D[LEU4,LYS8]-VP;

D[LEU4,LYS8]-VP 是血管加压素 V1b 受体的选择性激动剂，对大鼠，人类和小鼠 V1b 受体的 Ki 值分别为 0.16 nM，0.52 nM 和 1.38 nM。D[LEU4,LYS8]-VP 具有较弱的抗利尿剂、升压药和体外催产素活性。

D[LEU4,LYS8]-VPamp;;

D[LEU4,LYS8]-VP Chemical Structure

CAS No. : 42061-33-6

规格 是否有货
100 mg ; 询价 ;
250 mg ; 询价 ;
500 mg ; 询价 ;

* Please select Quantity before adding items.

D[LEU4,LYS8]-VP 的其他形式现货产品:

D[LEU4,LYS8]-VP TFA

生物活性

D[LEU4,LYS8]-VP is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. D[LEU4,LYS8]-VP has weak antidiuretic, vasopressor, and in vitro oxytocic activities[1][2].

IC50 Target

vasopressin V1b receptor[1]
分子量

1026.23

Formula

C47H67N11O11S2
CAS 号

42061-33-6
Sequence

{Mpa}-Tyr-Phe-Leu-Asn-Cys-Pro-Lys-Gly (Disulfide bridge:Mpa1-Cys6)
Sequence Shortening

{Mpa}-YFLNCPKG-NH2 (Disulfide bridge:Mpa1-Cys6)
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Solvent Solubility
In Vitro:;

H2O

Peptide Solubility and Storage Guidelines:

1.;;Calculate the length of the peptide.

2.;;Calculate the overall charge of the entire peptide according to the following table:

; Contents Assign value
Acidic amino acid Asp (D), Glu (E), and the C-terminal -COOH. -1
Basic amino acid Arg (R), Lys (K), His (H), and the N-terminal -NH2 +1
Neutral amino acid Gly (G), Ala (A), Leu (L), Ile (I), Val (V), Cys (C), Met (M), Thr (T), Ser (S), Phe (F), Tyr (Y), Trp (W), Pro (P), Asn (N), Gln (Q) 0

3.;;Recommended solution:

Overall charge of peptide Details
Negative (lt;0) 1.;;Try to dissolve the peptide in water first.
2.;;If water fails, add NH4OH (lt;50 μL).
3.;;If the peptide still does not dissolve, add DMSO (50-100 μL) to solubilize the peptide.
Positive (gt;0) 1.;;Try to dissolve the peptide in water first.
2.;;If water fails, try dissolving the peptide in a 10%-30% acetic acid solution.
3.;;If the peptide still does not dissolve, try dissolving the peptide in a small amount of DMSO.
Zero (=0) 1.;;Try to dissolve the peptide in organic solvent (acetonitrile, methanol, etc.) first.
2.;;For very hydrophobic peptides, try dissolving the peptide in a small amount of DMSO, and then dilute the solution with water to the desired concentration.
参考文献

  • [1]. Ana P, et, al. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors. Endocrinology. 2007 Sep; 148(9): 4136-46.

    [2]. Ana P, et, al. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. J Med Chem. 2007 Feb 22; 50(4): 835-47.

Etoposide(Synonyms: 依托泊苷; VP-16; VP-16-213)

发表于由

天然产物 天然产物苯丙素类 Phenylpropanoids

Etoposide (Synonyms: 依托泊苷; VP-16; VP-16-213) 纯度: 99.86%

Etoposide (VP-16; VP-16-213) 是一种常用的抗肿瘤化疗剂。Etoposide 抑制拓扑异构酶 II (topoisomerase-II)，从而抑制 DNA 复制。Etoposide 诱导细胞周期停滞，凋亡 (apoptosis) 和自噬 (autophagy)。

Etoposide(Synonyms: 依托泊苷; VP-16; VP-16-213)

Etoposide Chemical Structure

CAS No. : 33419-42-0

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
10 mM * 1 mL in DMSO ￥567 In-stock
100 mg ￥515 In-stock
200 mg ￥880 In-stock
500 mg ￥2000 In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Etoposide 相关产品

•相关化合物库:

  • Natural Product Library Plus
  • Drug Repurposing Compound Library Plus
  • FDA-Approved Drug Library Plus
  • FDA-Approved Drug Library Mini
  • Bioactive Compound Library Plus
  • Anti-Infection Compound Library
  • Apoptosis Compound Library
  • Cell Cycle/DNA Damage Compound Library
  • Natural Product Library
  • FDA-Approved Drug Library
  • Anti-Cancer Compound Library
  • Autophagy Compound Library
  • Anti-Aging Compound Library
  • Drug Repurposing Compound Library
  • Glycoside Compound Library
  • Antibacterial Compound Library
  • NMPA-Approved Drug Library
  • Phenols Library
  • Orally Active Compound Library
  • Traditional Chinese Medicine Monomer Library
  • FDA Approved & Pharmacopeial Drug Library
  • Antibiotics Library
  • Anti-Lung Cancer Compound Library
  • Drug-Induced Liver Injury (DILI) Compound Library
  • Anti-Blood Cancer Compound Library
  • Mitochondria-Targeted Compound Library
  • Tumorigenesis Related Compound Library
  • Rare Diseases Drug Library
  • Children’s Drug Library

生物活性

Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy[1].

IC50 & Target[1]

Topoisomerase II

 

体外研究
(In Vitro)

Etoposide is capable of causing cytotoxicity on pancreatic β-cells by inducing apoptosis through the JNK/ERK-mediated GSK-3 downstream-triggered mitochondria-dependent signaling pathway in RIN-m5F cells[1].
Etoposide and Anti-Human VEGF significantly abolish P1 sphere-forming ability, an effect associated with apoptosis of this subset of cells[2].
Etoposide phosphate (0-1μM; 72 hours) inhibits HCT116 FBXW+/+, FBXW-/- and p53-/- as a dose-dependent manner, exhibits IC50s of 0.945 μM; 0.375 μM; and 1.437 μM, respectively[5].
Etoposide (25 μM; 6 hours) delays p53 recover in FBXW7-deficient cells. In addition, FBXW7 expression is disappeared in FBXW7-/- cells[5].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[5]

Cell Line: HCT116 FBXW+/+, FBXW-/- and p53-/- cells
Concentration: 0.025 μM, 0.05 μM, 0.075 μM, 0.1 μM, 0.2 μM, 0.4 μM, 0.6 μM, 0.8 μM, 1 μM
Incubation Time: 72 hours
Result: Inhibits HCT116 FBXW+/+p>, FBXW-/- and p53-/- cell growth as a concentration manner.

Western Blot Analysis[5]

Cell Line: HCT116 FBXW7+/+ or FBXW7-/- cells
Concentration: 25 μM
Incubation Time: 6 hours
Result: Exhibited that the recovery of p53 levels after DNA damage is mediated by FBXW7.

体内研究
(In Vivo)

Etoposide (50 μM) and Anti-Human VEGF-treated hypoxic cells injected intravenously into immunodeficient mice reveals a reduced capacity to induce lung colonies, which also appear with a longer latency period[2]. Etoposide (10 mg/kg/day, i.v.) with NSC 109724 and NSC 241240, reduces the tumor volume in the hepatoblastoma cell injected NMRI nude mice[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial

分子量

588.56

Formula

C29H32O13
CAS 号

33419-42-0
中文名称

依托泊苷；臼乙叉苷；足叶乙甙
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶解性数据
In Vitro: 

DMSO : ≥ 39 mg/mL (66.26 mM)

* “≥” means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.6991 mL 8.4953 mL 16.9906 mL
5 mM 0.3398 mL 1.6991 mL 3.3981 mL
10 mM 0.1699 mL 0.8495 mL 1.6991 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂： 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (4.25 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (4.25 mM，饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液

  • 2.

    请依序添加每种溶剂： 10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (4.25 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (4.25 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

  • 3.

    请依序添加每种溶剂： 5% DMSO    40% PEG300    5% Tween-80    50% saline

    Solubility: ≥ 2.5 mg/mL (4.25 mM); Clear solution

  • 4.

    请依序添加每种溶剂： 5% DMSO    95% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (4.25 mM); Clear solution

  • 5.

    请依序添加每种溶剂： 1% DMSO    99% saline

    Solubility: ≥ 0.5 mg/mL (0.85 mM); Clear solution

*以上所有助溶剂都可在 MCE 网站选购。
参考文献

  • [1]. Lee KI, et al. Etoposide induces pancreatic β-cells cytotoxicity via the JNK/ERK/GSK-3 signaling-mediated mitochondria-dependent apoptosis pathway. Toxicol In Vitro. 2016 Jul 26. pii: S0887-2333(16)30147-3.

    [2]. Calvani M, det al. Etoposide-Anti-Human VEGF a new strategy against human melanoma cells expressing stem-like traits. Oncotarget. 2016 Jun 9. doi: 10.18632/oncotarget.9939.

    [3]. Fuchs, J., et al. Comparative activity of NSC 119875, NSC 109724, NSC 123127, NSC 241240, and etoposide in heterotransplanted hepatoblastoma. Cancer, 1998. 83(11): p. 2400-7.

    [4]. Hande KR, et al. The Importance of Drug Scheduling in Cancer Chemotherapy: Etoposide as an Example. Oncologist. 1996;1(4):234-239.

    [5]. Cui D, et al. FBXW7 Confers Radiation Survival by Targeting p53 for Degradation.Cell Rep. 2020 Jan 14;30(2):497-509.e4.

Mosloflavone

发表于由

天然产物 黄酮类 Flavonoids

Mosloflavone 

Mosloflavone 从 Scutellaria baicalensis Georgi 中分离出的类黄酮，具有抗 EV71 活性。Mosloflavone 在病毒感染的初始阶段抑制 VP2 病毒复制和蛋白质表达，并抑制病毒 VP2 衣壳蛋白合成。 Mosloflavone 是有前途的杀菌剂，可抑制铜绿假单胞菌的毒力和生物膜形成。

Mosloflavone

Mosloflavone Chemical Structure

CAS No. : 740-33-0

规格 价格 是否有货
5 mg ￥4030 询问价格 & 货期
10 mg ￥6860 询问价格 & 货期

* Please select Quantity before adding items.

生物活性

Mosloflavone is a flavonoid isolated from Scutellaria baicalensis Georgi with  anti-EV71 activity. Mosloflavone  inhibits VP2 virus replication and protein expression during the initial stage of virus infection and inhibits viral VP2 capsid protein synthesis. Mosloflavone is a promising biocide and inhibits P. aeruginosa virulence and biofilm formation.

IC50 & Target

IC50: EV71; bacterial[1][2]
体外研究
(In Vitro)

Mosloflavone shows promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 16.4 uM and 6.4 uM, respectively; inhibits TNF-α, IL-1β and iNOS levels in the supernatant of mouse macrophage cell line J774A as a dose-dependent manner, it also can be used as a starting point to discover lead structures for treatment of inflammatory and immunomodulatory diseases[2].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

298.29

Formula

C17H14O5
CAS 号

740-33-0
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. 2.Choi HJ, et al. Inhibitory Effects of Norwogonin, Oroxylin A, and Mosloflavone on Enterovirus 71.Biomol Ther (Seoul). 2016 Sep 1;24(5):552-8.

    [2]. 2.Hnamte S, et al. Mosloflavone attenuates the quorum sensing controlled virulence phenotypes and biofilm formation in Pseudomonas aeruginosa PAO1: In vitro, in vivo and in silico approach.Microb Pathog. 2019 Jun;131:128-134.

    [3]. 4.Singh B, et al. Anti-inflammatory and immunomodulatory flavones from Actinocarya tibetica Benth.Nat Prod Res. 2013;27(23):2227-30.

Millipore Stericup-VP 过滤器SCVPU02RE

发表于由

Millipore Stericup-VP 过滤器

简要描述：

型号 : SCVPU02RE

特点 :装有 Millipore Express PLUS 膜的 Stericup 过滤器将出众的流速与低的非特异性吸附相结合。 Millipore 密理博 SCVPU02RE Stericup-VP 过滤器，0.10 um，改良聚醚砜，250 mL，射线灭菌

详细描述

Millipore 密理博 SCVPU02RE Stericup-VP 过滤器，0.10 μm，改良聚醚砜，250 mL，射线灭菌

Stericup 真空过滤系统将 Steritop 过滤器与接收瓶相结合，用于处理和储存从150mL 到 1,000mL的液体。
其烧瓶设计新颖，无顶端附加物，易于紧握，而且外形紧凑，提高了过滤过程中的稳定性，很容易就可以握住接收瓶，在层流净化罩中使用Stericup 过滤器zui为理想。
接收瓶的底部稍稍内凹，方便储存时将带盖的瓶叠加堆积起来。

Millipore 密理博 SCVPU02RE Stericup-VP 过滤器，0.10 μm，改良聚醚砜，250 mL，射线灭菌

产品介绍

说明: Stericup-VP，0.10 μm，改良聚醚砜，250 mL，射线灭菌

商标名: Stericup

数量/包装: 12

应用: 快速、低蛋白质吸附，用于水溶液除菌和支原体去除

残留体积，mL: 3

进口接头: 漏斗

滤膜材质: Polyethersulfone

色码: 无色，但接头为蓝色

接收装置: 250 mL 瓶，带盖

直接病人护理，是/否: N

zui高操作温度，°C: 45

漏斗容量，mL: 250

处理体积，mL: 250

滤膜孔径，μm: 0.1

可润湿性: 亲水

灭菌: γ 射线照射

残留体积，μL: 3000

直径，mm: 125

滤膜直径，mm: 73

高度，mm: 164

产品名称: Stericup-VP 过滤器

无菌: 无菌

过滤面积，cm2: 40

装置材质: 聚苯乙烯

技术指标

材料  
装置 聚苯乙烯
过滤面积，cm2 40
处理体积，mL 150 至 1000
zui高操作温度，°C 45
灭菌方法 γ 射线照射
预过滤膜
可将一个 AP20 玻璃纤维圆片预过滤膜置于漏斗中滤膜之上，用一个调整卡片将其固定，以用于难以过滤的溶液。 预过滤膜必须单独订购：目录 编号 AP20 075 00，100 个/包装。

Millipore Sterivac-VP20 无菌盖式过滤器SKVPM20RJ SKGPM10RJ

发表于由

Millipore Sterivac-VP20 无菌盖式过滤器

简要描述：

型号 : SKVPM20RJ SKGPM10RJ SKGPM20RJ

特点 : Millipore 密理博 SKVPM20RJ, SKGPM10RJ, SKGPM20RJ, Sterivac 无菌盖式过滤器

详细描述

Millipore 密理博 SKVPM20RJ, SKGPM10RJ, SKGPM20RJ, Sterivac 无菌盖式过滤器

 

简单说明: Sterivac-VP，0.10μm，改良聚醚砜，4个/包装，射线灭菌
产品应用: 对组织滤膜和添加剂、蛋白质溶液、病毒悬浮液、DNA 及其它水溶液进行除菌过滤。 去除支原体
进口接头: 1/4″ 导管接头，用于真空样品进料
滤膜材质: 改良聚醚砜
滤器色码: 无色
膜商标名: Millipore Express
zui高操作温度: 45度
出口接头: 通用瓶口
处理体积: 15L
滤膜孔径: 0.1μm
可润湿性: 亲水
灭菌方式: γ 射线照射
残留体积: 10000μL
滤器直径: 76.2mm
滤器高度: 47.6mm
是否无菌: 无菌
过滤面积: 166cm2
装置材质: SAN/聚乙烯

anti-VP73 (NT), mAb (17B2) 抗VP73（NT）单抗（17B2） 品牌：AbFrontier

发表于由

anti-VP73 (NT), mAb (17B2)

抗VP73（NT）单抗（17B2）

品牌：AbFrontier
CAS No.：
储存条件：-20°C
纯度：–
产品编号

(生产商编号)

 等级 规格 运输包装 零售价(RMB) 库存情况 参考值

YIF-LF-MA0438

 – 100 ul –

anti-VP73 (NT), mAb (17B2) 抗VP73（NT）单抗（17B2） 品牌：AbFrontier

 – –


* 干冰运输、大包装及大批量的产品需酌情添加运输费用


* 零售价、促销产品折扣、运输费用、库存情况、产品及包装规格可能因各种原因有所变动，恕不另行通知，确切详情请联系上海金畔生物科技有限公司。

D[LEU4,LYS8]-VP TFA

发表于由

D[LEU4,LYS8]-VP TFA; 纯度: 98.16%

D[LEU4,LYS8]-VP TFA 是血管加压素 V1b 受体的选择性激动剂，对大鼠，人类和小鼠 V1b 受体的 Ki 值分别为 0.16 nM，0.52 nM 和 1.38 nM。D[LEU4,LYS8]-VP TFA 具有较弱的抗利尿剂、升压药和体外催产素活性。

D[LEU4,LYS8]-VP TFAamp;;

D[LEU4,LYS8]-VP TFA Chemical Structure

规格 价格 是否有货 数量
5 mg ￥800 In-stock
10 mg ￥1300 In-stock
50 mg ; 询价 ;
100 mg ; 询价 ;

* Please select Quantity before adding items.

D[LEU4,LYS8]-VP TFA 相关产品

bull;相关化合物库:

  • Bioactive Compound Library Plus
  • GPCR/G Protein Compound Library
  • Macrocyclic Compound Library
  • Anti-Cardiovascular Disease Compound Library
  • Peptide Library

生物活性

D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. D[LEU4,LYS8]-VP TFA has weak antidiuretic, vasopressor, and in vitro oxytocic activities[1][2].

IC50 Target

vasopressin V1b receptor[1]
分子量

1140.25

Formula

C49H68F3N11O13S2
Sequence

{Mpa}-Tyr-Phe-Leu-Asn-Cys-Pro-Lys-Gly (Disulfide bridge:Mpa1-Cys6)
Sequence Shortening

{Mpa}-YFLNCPKG-NH2 (Disulfide bridge:Mpa1-Cys6)
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Sealed storage, away from moisture

Powder -80deg;C 2 years
-20deg;C 1 year

*In solvent : -80deg;C, 6 months; -20deg;C, 1 month (sealed storage, away from moisture)
Solvent Solubility
In Vitro:;

H2O

Peptide Solubility and Storage Guidelines:

1.;;Calculate the length of the peptide.

2.;;Calculate the overall charge of the entire peptide according to the following table:

; Contents Assign value
Acidic amino acid Asp (D), Glu (E), and the C-terminal -COOH. -1
Basic amino acid Arg (R), Lys (K), His (H), and the N-terminal -NH2 +1
Neutral amino acid Gly (G), Ala (A), Leu (L), Ile (I), Val (V), Cys (C), Met (M), Thr (T), Ser (S), Phe (F), Tyr (Y), Trp (W), Pro (P), Asn (N), Gln (Q) 0

3.;;Recommended solution:

Overall charge of peptide Details
Negative (lt;0) 1.;;Try to dissolve the peptide in water first.
2.;;If water fails, add NH4OH (lt;50 μL).
3.;;If the peptide still does not dissolve, add DMSO (50-100 μL) to solubilize the peptide.
Positive (gt;0) 1.;;Try to dissolve the peptide in water first.
2.;;If water fails, try dissolving the peptide in a 10%-30% acetic acid solution.
3.;;If the peptide still does not dissolve, try dissolving the peptide in a small amount of DMSO.
Zero (=0) 1.;;Try to dissolve the peptide in organic solvent (acetonitrile, methanol, etc.) first.
2.;;For very hydrophobic peptides, try dissolving the peptide in a small amount of DMSO, and then dilute the solution with water to the desired concentration.
参考文献

  • [1]. Ana P, et, al. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors. Endocrinology. 2007 Sep; 148(9): 4136-46.

    [2]. Ana P, et, al. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. J Med Chem. 2007 Feb 22; 50(4): 835-47.

anti-VP73 (N-Term), pAb 抗VP73（N-端）多抗 品牌：AbFrontier

发表于由

anti-VP73 (N-Term), pAb

抗VP73（N-端）多抗

品牌：AbFrontier
CAS No.：
储存条件：-20°C
纯度：–
产品编号

(生产商编号)

 等级 规格 运输包装 零售价(RMB) 库存情况 参考值

YIF-LF-PA0263

 – 100 ul –

anti-VP73 (N-Term), pAb 抗VP73（N-端）多抗 品牌：AbFrontier

 – –


* 干冰运输、大包装及大批量的产品需酌情添加运输费用


* 零售价、促销产品折扣、运输费用、库存情况、产品及包装规格可能因各种原因有所变动，恕不另行通知，确切详情请联系上海金畔生物科技有限公司。

anti-VP73 (CT), pAb 抗VP73（CT）多抗 品牌：AbFrontier

发表于由

anti-VP73 (CT), pAb

抗VP73（CT）多抗

品牌：AbFrontier
CAS No.：
储存条件：-20°C
纯度：–
产品编号

(生产商编号)

 等级 规格 运输包装 零售价(RMB) 库存情况 参考值

YIF-LF-PA0287

 – 100 ul –

anti-VP73 (CT), pAb 抗VP73（CT）多抗 品牌：AbFrontier

 – –


* 干冰运输、大包装及大批量的产品需酌情添加运输费用


* 零售价、促销产品折扣、运输费用、库存情况、产品及包装规格可能因各种原因有所变动，恕不另行通知，确切详情请联系上海金畔生物科技有限公司。